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Abstract
Background: In recent years, YouTube has become a recognized source of medical information for health care consumers.
Although YouTube has advantages in this context, there are potential dangers as videos may contain nonscientific, misleading,
or even harmful information.
Objective: As little is known about YouTube as a source of information on atopic dermatitis (AD), we investigated the
content-related quality of AD videos and their perception among YouTube users.
Methods: The quality of the 100 most viewed AD videos was assessed by using the Global Quality Scale (GQS) and the
DISCERN instrument. Videos were classified as “useful,” “misleading,” and “potentially harmful,” and the correlations of viewers’
ratings (likes) with the GQS and DISCERN scores were assessed.
Results: Among the 100 videos, 68.0% (68/100) and 62.0% (62/100) were of poor and very poor scientific quality, respectively.
Additionally, 32.0% (32/100) of the videos were classified as useful, 48.0% (48/100) were classified as misleading, and 34.0%
(34/100) were classified as potentially harmful. Viewers’ ratings did not correlate with the GQS and DISCERN scores. Overall,
50.0% (50/100) of the videos were posted by private individuals and promoters of complementary/alternative treatments, 42.0%
(42/100) by therapeutical advertisers, and only 8.0% (8/100) by nonprofit organizations/universities.
Conclusions: Our study demonstrated that two-thirds of the videos analyzed were below acceptable medical quality standards
and that many videos were disseminating misleading or even dangerous content. Subjective and anecdotal content was
overrepresented, and viewers did not appear to be able to distinguish between high- and low-quality videos. Health promotion
strategies by professional medical organizations are needed to improve their presence and visibility on YouTube.
(J Med Internet Res 2020;22(4):e15599) doi: 10.2196/15599
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Introduction
Atopic dermatitis (AD), also known as atopic eczema, is the
most common chronic inflammatory skin disease during
childhood [1] and is characterized by recurrent itchy eczematous
lesions [2]. Globally, up to 20% of children and 3% of adults
are affected by this condition [2]. Patients experience not only
the disease itself (eg, sleep deprivation due to night-time
itching), but also the stigma associated with its visibility to
others. As a result, patients with AD are often frustrated and
embarrassed, which may lead to stress and perpetuation of an
itch-scratch cycle, eventually worsening the condition [3].
Consequently, patients and their families frequently report a
low health-related quality of life [3,4]. Considering that a high
proportion of patients with skin diseases show high interest in
online searches [5], patients with AD may be particularly
tempted to seek information about their condition from the
internet or social media for the aforementioned reasons.
YouTube is such a video-based social media platform that allows
users to communicate and share their disease burden and
individual experience through videos, which can receive
comments [6]. It is currently the second most accessed website
worldwide [7], attracting approximately one-third of all internet
users [8]. YouTube has an increasing number of videos
containing medical information [9-11], which may disseminate
inaccurate details owing to the lack of quality control and may
cause severe health consequences [9,12]. Although several
studies have demonstrated that YouTube is highly accessed as
a source of information on dermatological topics [13-22], little
is known about YouTube as a source of information on AD.
This may be surprising given the high prevalence of this
condition and the assumption that the populations most affected
(children, adolescents, and their parents) typically belong to the
age group of “digital natives” (persons born from 1980 onward)
[23]. A previous publication indicated that YouTube videos are
indeed highly accessed, commented, and shared in connection
with AD and that many of the videos posted provide misleading
guidance [24]. However, to the best of our knowledge, there
have been no in-depth analyses of the topics posted, quality of
medical content, upload sources, and ratings by viewers.
Therefore, the objectives of this study were as follows: (1)
identify the upload sources, common topics, and YouTube
categories of the 100 most viewed videos; (2) investigate the
content-related quality of YouTube videos as a source of
information on AD by applying two different score instruments;
(3) correlate viewers’ ratings with our quality assessment
findings; and (4) point out strategies for interventions that
increase the quality of AD videos and medical content generally
uploaded to YouTube and other social media platforms.
Methods
Data Collection
In this cross-sectional study, YouTube was searched on April
18, 2018, using the term “atopic eczema” with the following
filter settings: “English UK” (language), “United Kingdom”
(country), and “Video” (type). Thereafter, videos were sorted
by view count, and the duration, upload date, title, URL, view
count, uploader identity, likes/dislikes, category, license type,
and origin country were recorded and analyzed. In August 2018,
videos were reviewed in more detail. Although categories were
re-evaluated and refined, we did not update or change numbers
and video rankings. We excluded videos having poor technical
quality, duplicate videos, and nonEnglish videos, unless English
subtitles were displayed. Similar to many previous studies about
YouTube, we limited our analysis to the 100 most viewed videos
(Multimedia Appendix 1), as it has been demonstrated that
videos rated lower than this have insignificant view counts with
a minor impact on the analysis [22,25-28].
Creation of Content Topics
After gathering data, videos were categorized into themes
according to the actual content presented irrespective of the
titles. The following 12 categories were created: “education,”
“topical treatment,” “systemic treatment,” “complementary and
alternative medicine (CAM),” “food, nutrition, and diet,”
“bathing/wet wrapping,” “ultraviolet (UV) treatment,” “irritants
(clothing, sweat, heat, and allergens),” “stress prevention,”
“therapeutical advertisement,” “unclear topic,” and “other
topics.” Therapeutical advertising included both
nonpharmaceutical and pharmaceutical advertising.
Quality Assessment
The two frequently used quality assessments DISCERN (name
of the instrument) and Global Quality Scale (GQS) were applied
to evaluate the medical quality of the posted videos [25,29-33].
DISCERN measures a video’s quality of information about
treatment choices. It includes 16 questions addressing the
reliability (questions 1-8), quality of health information
(questions 9-15), and overall quality (question 16) of the videos.
To each of these questions 1-5 points were assigned [31,34,35]
(Multimedia Appendix 2). The GQS is based on a 5-point scale
measuring the content-related quality of a video, its flow, and
its value as a source of information for medical laypeople
[14,25,29,30,36,37] (Multimedia Appendix 3). The classification
shown in Figure 1 (1=not at all useful, 2=of very limited use,
3=somewhat useful, 4=useful, and 5=very useful) was adopted
from the report by Qi et al [14]. As both DISCERN and the
GQS are based on a 5-point scale, the same classification was
used. In addition, videos were classified as “useful” or
“misleading,” where useful videos had scientifically correct and
accurate information about any aspect of the disease and
misleading videos had scientifically unproven or inaccurate
information according to currently available scientific evidence
(eg, unfounded claims about pathogenesis and treatment with
unproven dietary, herbal, or alternative therapy or negative
portrayal of evidence-based treatment) [30,32]. If a video could
not be assigned to one of these groups, it was automatically
classified as “neither nor.” Further, misleading videos were
subdivided into “potentially harmful” and “not harmful.” To
assess the role of background music in terms of video popularity,
we performed correlation calculations with the numbers of likes
and views. Regarding all features, in case of different
assessments by the analyzing dermatologists, the corresponding
videos were re-evaluated and arbitrated by the principal
investigator.
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Figure 1. Comparison of the overall quality and usefulness of the identified videos (n=100) for patients seeking health-related advice, using the
DISCERN instrument and the Global Quality Scale. The overall rating of DISCERN refers to question 16 of this tool, which is based on a 5-point scale
(Multimedia Appendix 2).
Statistical Analysis
Analyses involving descriptive statistics and Spearman rank
correlation coefficients for the numbers of likes/dislikes and
the DISCERN and GQS scores were performed using IBM
SPSS statistics, version 22.0 (IBM Corp, Armonk, New York).
For evaluation of the degree of agreement among reviewers
(seven experienced dermatologists listed as authors, except for
ZRM, OF, and AN) regarding the videos, Cohen κ coefficients
and intraclass correlation coefficients were calculated.
Results
View Count, Duration, Upload Sources, Categories,
and Topics
The 100 most viewed videos garnered a total of 8,527,624 views
and had a total duration of 7 hours 52 minutes (average duration
of 4 minutes 44 seconds per video). All videos had a standard
YouTube license, which allows the use of the videos only after
obtaining permission from the author [38]. Most clips were
uploaded from the United States (43.0%, 43/100), followed by
unknown countries (14.0%, 14/100) and India (12.0%, 12/100)
(Multimedia Appendix 4). The category most often used by the
upload source was people & blogs (34.0%, 34/100), followed
by education (24.0%, 24/100), how-to & style (22.0%, 22/100),
science & technology (11.0%, 11/100), nonprofits & activism
(7.0%, 7/100), entertainment (1.0%, 1/100), and news & politics
(1.0%, 1/100) (Multimedia Appendix 5A). The most frequent
topic (a video can cover more than one topic) was topical
treatment (55.0%, 55/100), followed by education (38.0%,
38/100; eg, pathogenesis, risk factors, and instructions for
wet-wrapping techniques), food, nutrition, and diet (28.0%,
28/100), CAM (26.0%, 26/100), bathing/wet wrapping (26.0%,
26/100), systemic treatment (15.0%, 15/100), unclear topic
(15.0%, 15/100), other topics (13.0%, 13/100), irritants (12.0%,
12/100; clothing, sweat, heat, and allergens), therapeutical
advertisement (10.0%, 10/100), UV treatment (5.0%, 5/100),
and stress prevention (4.0%, 4/100) (Multimedia Appendix 5B).
Regarding information presenters and upload sources of videos
on AD (a video can cover more than one category), the most
common were YouTube users with personal experiences and
promoters of CAM (50.0%, 50/100), followed by alleged
patients (49.0%, 49/100), therapeutical advertisers (42.0%,
42/100), dermatologists or scientists (32.0%, 32/100), health
information websites and eczema associations (21.0%, 21/100),
nonprofit organizations and universities (8.0%, 8/100), and
television/media (6.0%, 6/100) (Multimedia Appendix 6).
Videos featuring only patients had approximately 421,181 views,
whereas those featuring only dermatologists/scientists had
120,736 views. Background music was used in 51.0% (51/100)
of all videos, and these had 823,924 views and 3,481 likes.
Background music-containing videos accounted for 53.01%
(823,924/1,554,155) of the total view count and had 42.40%
(3,481/8,210) of all likes. For none of the videos, YouTube
statistics were accessible, whereas the comment function was
disabled in only 6.0% (6/100) of the videos.
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Quality Assessment and Correlation With
Likes/Dislikes
Overall, 32.0% (32/100) of the videos were classified as useful,
48.0% (48/100) were classified as misleading, and 20.0%
(20/100) were classified as neither nor. Among those classified
as misleading, 71% (34/48) were considered potentially harmful
because of possible mechanical or chemical injury or inadequate
dietary recommendations and 29% (14/48) were considered not
harmful (Multimedia Appendix 7A). Regarding nonscientific
and potentially harmful videos, 37% (15/41) suggested
unnecessary diets, 19% (8/41) discredited conventional medicine
and physician advice, 15% (6/41) made unrealistic promises,
17% (7/41) did not limit the use of UV treatments, topical
steroids, antibiotics, or cold packs, 7% (3/41) promoted the use
of unscientific and potentially harmful procedures, and 5%
(2/41) recommended topical use of potentially harmful
substances (Multimedia Appendix 7B). The mean durations of
useful and misleading videos were 6 minutes 2 seconds and 3
minutes 39 seconds, respectively. Regarding the view count,
we excluded the most viewed video from further analysis, as it
was a pharmaceutical advertisement with disabled like/dislike
and comment functions, accounting for approximately 81.78%
(6,973,469/8,527,624) of all views. In total, misleading videos
had 870,012 views, including 789,073 views for potentially
dangerous content, whereas useful videos had only 528,352
views, resulting in a misleading/useful video ratio of 1.65
(870,012/528,352).
The ratings achieved with DISCERN and the GQS were
consistent, yielding the categorizations shown in Figure 1. With
regard to the quality of videos, the mean overall DISCERN and
GQS scores were 1.99 (SD 1.09) and 2.12 (SD 1.09),
respectively, and therefore, quality was generally low, as the
scores range from 1 to 5, with 5 being the highest value. Detailed
analysis of the DISCERN questionnaire revealed that the major
shortcomings were lack of details about the source of the
presented information, unaddressed areas of uncertainty as well
as risks of the presented therapy, and failure to recommend
shared decision-making (Figure 2). The intraclass correlation
coefficients calculated for DISCERN and the GQS were 0.97
and 0.95, respectively, indicating excellent interrater reliability
when using these tools.
Figure 2. Detailed analysis of the DISCERN questionnaire (questions 1-15) used to rate the identified videos (n=100). The instrument uses a 5-point
scale ranging from no to yes, where 1 means “no” (the quality criterion has not been fulfilled at all), 2-4 means “partially” (the quality criterion has
been fulfilled to some extent), and 5 means “yes” (the quality criterion has been completely fulfilled).
The total numbers of likes and dislikes for the videos were 8210
and 737, respectively, yielding a like/dislike ratio of 11.14
(8210/737). In three videos, the like/dislike function was
disabled. Viewers’ ratings did not correlate with the DISCERN
and GQS scores (Spearman correlation ρ=0.12, P=.25 and
ρ=0.17, P=.08, respectively), indicating that viewers were
unable to adequately rate the quality of the videos.
Discussion
Overview
Patients with AD have a high motivation to conduct online
searches, and this usually correlates with disease burden [39,40].
YouTube offers a wide range of dermatology-related videos
[13], and little is known so far about the content, upload sources,
topics, and scientific quality of these videos. Hitherto, no data
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exist on whether viewers’ ratings correlate with the quality of
the medical information provided.
This study revealed that nearly half of the 100 most viewed
AD-related videos on YouTube, with more than 8.5 million
views, disseminated misleading information. This finding is
consistent with the findings of our previously published study
[22] and several other surveys investigating the content-related
quality of health-related YouTube videos [12,41,42].
Comparison With Prior Work
Freemyer et al [24] thoroughly analyzed 128 videos that were
gathered by screening the first two result pages of each of the
five different search terms (AD, eczema, eczema tips, eczema
cure, and eczema treatment) they used for AD. In contrast to
our study, they distinguished between “useful,”
“useful-personal,” “misleading,” and “misleading-personal”
information but not between “harmful” and “neutral”
information, and therefore, they found that only 34.4% (44/128)
of the videos were misleading. A reason for the markedly lower
percentage of misleading videos may be the different search
terms used to identify the respective videos. Although a study
from 2016 showed that AD is the most commonly used term
among scientific publications and studies [43], patients use the
nonspecific term eczema to refer to AD [44]. As the purpose of
this study was to investigate the video sample patients would
come across when seeking information online, we decided to
use the term atopic eczema to search YouTube. In contrast to
the approach by Freemyer et al [24], we additionally sorted the
search results by view count to obtain a video sample of high
relevance owing to large viewership. Another aspect that makes
direct comparison with our study nearly impossible is the
absence of quality assessment tools in the mentioned study.
Videos of Good or Excellent Quality are Rare
According to our evaluation using DISCERN and the GQS,
only 11.0% (11/100) and 13.0% (13/100) of the videos,
respectively, were of good or excellent quality with unbiased
evidence-based or at least science-based information. Similar
results were obtained in our recently published study
investigating YouTube videos on psoriasis [22]. Additionally,
data by Freemyer et al [24] demonstrated that health care
organizations, universities, and dermatologists are clearly
underrepresented on YouTube in the context of AD.
YouTube Users Prefer Low-Quality Videos Over
High-Quality Videos
Factual and informative videos are rare, and they lack popularity,
as illustrated by the lower number of likes compared to those
of poor-quality videos. Our previous study and many other
dermatological and nondermatological studies have come to
similar conclusions regarding this phenomenon [14,22,41,45].
It remains unclear why the general population tends to prefer
low-quality videos over high-quality videos. Biggs et al [46]
suggested that the duration of the videos might be a relevant
issue. Similar to the findings in their study (mean useful video
duration: 14 minutes 47 seconds; mean misleading video
duration: 4 minutes 37 seconds), we found that longer videos
were associated with higher quality. In our study, useful videos
were nearly twice as long as misleading videos (mean useful
video duration: 6 minutes 2 seconds; mean misleading video
duration: 3 minutes 39 seconds), which could indeed be enough
time to put off viewers looking for quick answers. Additional
reasons could be that viewers specifically search for alternative
content, which is usually present in videos of lower quality, and
that academic videos may be less sensationalized and thus less
attractive to laypersons [22,37].
Patients Prefer Advice From Fellow Patients Rather
Than Physicians
Interestingly, one or more patients appeared in 49.0% (49/100)
of all videos regardless of whether the video was produced by
them. Of note, only 32.0% (32/100) of all videos featured a
dermatologist or scientist. Analyzing the separate view count,
we found that videos featuring only patients had nearly 3.5 times
more views as compared with videos featuring only
dermatologists/scientists (only patients: 421,181 views; only
dermatologists/scientists: 120,736 views). Smith et al [47]
showed that 70% of patients with chronic conditions reported
experiencing one or more health care–related frustrations, such
as the feeling of not being understood or taken seriously (ie,
lack of empathy by the physician). Therefore, patients might
follow the advice of fellow patients with the same disease rather
than the instructions of health care professionals. This decision
is obviously frequently made despite poor video quality.
Potentially Harmful Content
In our study, 34.0% (34/100) of the analyzed videos contained
potentially harmful information. For instance, patients with AD
were encouraged to not only follow unnecessary diets, such as
avoid dairy or gluten, but also use topical treatments (eg, cold
packs) and phototherapies without any detailed information
about the duration of application or potential risks. Furthermore,
conventional medicine and physician advice were discredited
in various ways, while promising a fast and easy cure at the
same time with the suggested therapies. Such advice was often
provided by therapeutical commercials that tried to sell their
products, as well as by patients who reported personal negative
long-term experiences with Western conventional medicine and
eventually found salvation in alternative treatments.
Interestingly, these testimonials were frequently uploaded from
India (accounting for 12.0% [12/100] of all videos investigated)
and typically showed parents being enthusiastic about a
traditional practice that healed their children who had atopic
eczema.
Complementary and Alternative Medicine is a Hot
Topic for YouTube Users
The confidence and high interest in CAM described above are
comprehensible considering that 70%-80% of India’s population
is dependent on traditional systems for financing health care
[48]. However, this enthusiasm about CAM appears to be shared
by the rest of the world as well, because 50.0% (50/100) of the
AD-related videos were uploaded by CAM promoters and
YouTube users sharing their personal experiences. Reddy et al
[37] recently reported the similarly dominant and controversial
role of CAM in YouTube videos on food allergy. This may not
be surprising considering that the question of food allergies
underlying or aggravating AD is important among most affected
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patients or their parents (particularly in infancy) but is often
difficult to answer for clinicians.
Extensive Advertising
Another astonishing fact is that therapeutical advertisers
uploaded 42.0% (42/100) of all videos investigated, although
the advertised product did not necessarily appear in the video.
As YouTube has become an important marketing platform over
the last decade, the advertisement of products with referral links
has increased in popularity [49]. Small- and medium-sized
companies, in particular, can benefit from social media
marketing, as a large number of potential customers can be
reached at a relatively low cost [50]. This trend can be an issue
for online health information seekers trying to find valid
guidance, as commercial advertisements are being disguised as
supposedly harmless referral links.
Along with a lack of quality recognition and an intentional
search for unconventional content, a lack of entertainment may
explain why fewer people are attracted to high-quality videos
than to low-quality videos [22]. When examining view count
and number of likes with background music as a possible
clickbait factor, we found that the majority of likes were
generated by videos without background music, suggesting that
background music does not markedly increase the popularity
of videos and is thus not a suitable strategy to attract people to
high-quality videos.
A greater understanding of what kinds of measures attract a
high number of viewers is pivotal for enabling health care
organizations, universities, and dermatologists to appeal to more
patients.
Potential Interventions to Improve the Presence and
Visibility of High-Quality Videos
As the need for content-related high-quality online material is
indisputable, dermatology associations, AD self-help
organizations, and universities should be encouraged to produce
and provide more videos containing evidence-based
easy-to-understand information about pathophysiology, clinical
manifestations, and therapies for patients with AD and their
families, and at the same time, they need to highlight the dangers
of non–evidence-based treatment options [22]. Prior to the
release of videos, measures for quality assessment (eg, the
DISCERN tool) should be applied to ensure high-quality
content. In the long term, this approach could result in the
neutralization of widely available misleading information on
YouTube.
Additionally, professionals need to be aware of the fact that
health information seekers mostly choose results that appear on
the first page of the search engine [51] when looking for medical
content online, and therefore, need to make sure that videos
appear there. Investing in consulting services that improve the
placement of information in search engines on a website (search
engine optimization) could be more efficient than producing
additional videos that are placed somewhere beyond the second
results page [52]. In addition, it would be advantageous if both
social media and search engine providers are encouraged to
cooperate with dermatology associations and universities to
position medically accurate information near the top of the
results page.
Moreover, the use of a Creative Commons license instead of a
standard YouTube license could lead to more visits, as has been
shown in our previous study [22]. This kind of license allows
individuals to use content for their own video clips [53,54].
However, it is advisable to choose a license type that forbids
others to change the content in any way or to use it
commercially, as misuse that can potentially result in misleading
information should be prevented.
Finally, the comment section of misleading videos could be
used to insert cross-links to guide viewers to trustworthy videos
or websites with evidence-based information. For this approach
to work, the comment function must not be disabled by the
producer of the video in question, and therefore, unfortunately,
this is not a feasible intervention for every video on YouTube.
Strengths and Limitations
Despite the unmistakable strengths, such as the comprehensive
analyses of a high number of videos and the application of two
different scoring tools (GQS and DISCERN), this study has
some limitations. Although we performed comprehensive
analyses, we did not evaluate the comments posted by viewers,
which may contain the viewers’ true opinions about a particular
video and thus its popularity. Additionally, we did not evaluate
the visual design of the videos using a specific tool solely
developed for this purpose, making it possible that the impact
of the videos on the viewers was not fully captured in this
respect. Furthermore, our study is specific for an arbitrary period
and therefore only includes the material available at that time.
Finally, additional factors, such as instructional design and
educational value, contributing to the overall quality of the
videos were not assessed in this study. These aspects may
certainly be worth investigating in future studies with novel
assessment tools. In addition, we would like to mention that
besides the assessment tools used in this study, there are other
valid methods to measure the information accuracy and content
quality of YouTube videos [55].
Conclusion
This study showed that two-thirds of the videos on AD analyzed
were below acceptable medical quality standards and often
contained misleading or even harmful information about this
common disease. The fact that users tended to rate low-quality
videos better than high-quality videos suggests that the majority
of users are unable to distinguish between medically credible
information and false information. This shows that the numbers
of views and likes do not reflect the medical quality of videos.
To combat this phenomenon, it is crucial that future studies
investigate user motivation for such behavior in order to help
medical professionals to develop approaches that contribute to
improving medical information on this powerful platform.
Conflicts of Interest
None declared.
J Med Internet Res 2020 | vol. 22 | iss. 4 | e15599 | p. 6https://www.jmir.org/2020/4/e15599
(page number not for citation purposes)
Mueller et alJOURNAL OF MEDICAL INTERNET RESEARCH
XSL•FO
RenderX
Authors' Contributions
SMM and VNSH contributed equally as first authors. OB and KS contributed equally as last authors.
Multimedia Appendix 1
Links to the YouTube videos.
[XLSX File (Microsoft Excel File), 19 KB-Multimedia Appendix 1]
Multimedia Appendix 2
DISCERN instrument.
[PDF File (Adobe PDF File), 33 KB-Multimedia Appendix 2]
Multimedia Appendix 3
Global Quality Scale (GQS).
[PDF File (Adobe PDF File), 31 KB-Multimedia Appendix 3]
Multimedia Appendix 4
Distribution of the videos by country of origin.
[PDF File (Adobe PDF File), 22 KB-Multimedia Appendix 4]
Multimedia Appendix 5
(A) YouTube categories, in which the analyzed videos were posted (n=100); (B) Topics presented in the videos (note: a video
clip can cover more than one topic).
[PDF File (Adobe PDF File), 34 KB-Multimedia Appendix 5]
Multimedia Appendix 6
Distribution of information according to presenters and upload sources (multiple categories may apply to one video). CAM,
complementary and alternative medicine.
[PDF File (Adobe PDF File), 25 KB-Multimedia Appendix 6]
Multimedia Appendix 7
(A) Classification of the videos (n=100) into “useful,” “misleading,” and “neither nor,” with further subdivision of “misleading”
into "potentially harmful” and “not harmful” (not harmful = 48 misleading videos minus potentially harmful videos [14, 29%])
shown as a bar chart (in percentage); (B) Specifications and examples of nonscientific and potentially harmful videos.
[PDF File (Adobe PDF File), 26 KB-Multimedia Appendix 7]
References
1. Flohr C, Mann J. New insights into the epidemiology of childhood atopic dermatitis. Allergy 2014 Jan;69(1):3-16. [doi:
10.1111/all.12270] [Medline: 24417229]
2. Nutten S. Atopic dermatitis: global epidemiology and risk factors. Ann Nutr Metab 2015;66 Suppl 1:8-16 [FREE Full text]
[doi: 10.1159/000370220] [Medline: 25925336]
3. Carroll CL, Balkrishnan R, Feldman SR, Fleischer AB, Manuel JC. The burden of atopic dermatitis: impact on the patient,
family, and society. Pediatr Dermatol 2005;22(3):192-199. [doi: 10.1111/j.1525-1470.2005.22303.x] [Medline: 15916563]
4. Lewis-Jones S. Quality of life and childhood atopic dermatitis: the misery of living with childhood eczema. Int J Clin Pract
2006 Aug;60(8):984-992. [doi: 10.1111/j.1742-1241.2006.01047.x] [Medline: 16893440]
5. Whitsitt J, Karimkhani C, Boyers LN, Lott JP, Dellavalle RP. Comparing burden of dermatologic disease to search interest
on google trends. Dermatol Online J 2015 Jan;21(1). [Medline: 25612125]
6. Samuel N, Alotaibi NM, Lozano AM. YouTube as a Source of Information on Neurosurgery. World Neurosurg 2017
Sep;105:394-398. [doi: 10.1016/j.wneu.2017.05.111] [Medline: 28599904]
7. Alexa. Website traffic analysis URL: https://www.alexa.com/siteinfo/youtube.com [accessed 2018-08-29]
8. Omnicore. YouTube by the Numbers: Stats, Demographics & Fun Facts URL: https://www.omnicoreagency.com/youtube-
[accessed 2018-08-29]
9. Raikos A, Waidyasekara P. How useful is YouTube in learning heart anatomy? Anat Sci Educ 2014 Feb;7(1):12-18. [doi:
10.1002/ase.1361] [Medline: 23564745]
J Med Internet Res 2020 | vol. 22 | iss. 4 | e15599 | p. 7https://www.jmir.org/2020/4/e15599
(page number not for citation purposes)
Mueller et alJOURNAL OF MEDICAL INTERNET RESEARCH
XSL•FO
RenderX
10. Madathil KC, Rivera-Rodriguez AJ, Greenstein JS, Gramopadhye AK. Healthcare information on YouTube: A systematic
review. Health Informatics J 2015 Sep;21(3):173-194. [doi: 10.1177/1460458213512220] [Medline: 24670899]
11. Karlsen R, Borrás Morell JE, Fernández Luque L, Traver Salcedo V. A domain-based approach for retrieving trustworthy
health videos from YouTube. Stud Health Technol Inform 2013;192:1008. [Medline: 23920782]
12. Abedin T, Ahmed S, Al MM, Ahmed SW, Newaz S, Rumana N, et al. YouTube as a source of useful information on
diabetes foot care. Diabetes Res Clin Pract 2015 Oct;110(1):e1-e4. [doi: 10.1016/j.diabres.2015.08.003] [Medline: 26303266]
13. Boyers LN, Quest T, Karimkhani C, Connett J, Dellavalle RP. Dermatology on YouTube. Dermatol Online J 2014 Jun
15;20(6) [FREE Full text] [Medline: 24945641]
14. Qi J, Trang T, Doong J, Kang S, Chien AL. Misinformation is prevalent in psoriasis-related YouTube videos. Dermatol
Online J 2016 Nov 15;22(11). [Medline: 28329562]
15. Lenczowski E, Dahiya M. Psoriasis and the Digital Landscape: YouTube as an Information Source for Patients and Medical
Professionals. J Clin Aesthet Dermatol 2018 Mar;11(3):36-38 [FREE Full text] [Medline: 29606999]
16. Qureshi N, Lowenstein EJ. The role of nutrition in acne pathogenesis: YouTube as a reflection of current popular thought.
Skinmed 2011;9(5):279-280. [Medline: 22165041]
17. Pithadia DJ, Reynolds KA, Lee EB, Wu JJ. A cross-sectional study of YouTube videos as a source of patient information
about topical psoriasis therapies. J Dermatolog Treat 2019 May 18:1-4. [doi: 10.1080/09546634.2019.1597247] [Medline:
30885022]
18. Pithadia DJ, Reynolds KA, Lee EB, Wu JJ. A cross-sectional study of YouTube videos as a source of patient information
about phototherapy and excimer laser for psoriasis. J Dermatolog Treat 2019 Apr 09:1-4. [doi:
10.1080/09546634.2019.1605144] [Medline: 30963794]
19. St Claire KM, Rietcheck HR, Patel RR, Dunnick C, Dellavalle RP. Dermatology on YouTube - an update and analysis of
new trends. Dermatol Online J 2018 Dec 15;24(12) [FREE Full text] [Medline: 30677792]
20. Reynolds KA, Pithadia DJ, Lee EB, Wu JJ. A cross-sectional study of YouTube videos about psoriasis biologics. Int J
Dermatol 2019 May;58(3):e61-e62. [doi: 10.1111/ijd.14317] [Medline: 30478827]
21. DeBord LC, Patel V, Braun TL, Dao H. Social media in dermatology: clinical relevance, academic value, and trends across
platforms. J Dermatolog Treat 2019 Aug;30(5):511-518. [doi: 10.1080/09546634.2018.1530444] [Medline: 30265614]
22. Mueller SM, Jungo P, Cajacob L, Schwegler S, Itin P, Brandt O. The Absence of Evidence is Evidence of Non-Sense:
Cross-Sectional Study on the Quality of Psoriasis-Related Videos on YouTube and Their Reception by Health Seekers. J
Med Internet Res 2019 Jan 16;21(1):e11935 [FREE Full text] [doi: 10.2196/11935] [Medline: 30664460]
23. Zaphiris P, Ioannou A. Learning and Collaboration Technologies. LearningTeaching. 2018 Presented at: 5th International
Conference, LCT 2018, Held as Part of HCI International 2018; July 15-20, 2018; Las Vegas, NV, USA. [doi:
10.1007/978-3-319-91152-6]
24. Freemyer B, Drozd B, Suarez A. A cross-sectional study of YouTube videos about atopic dermatitis. J Am Acad Dermatol
2018 Mar;78(3):612-613. [doi: 10.1016/j.jaad.2017.09.005] [Medline: 29447681]
25. Oremule B, Patel A, Orekoya O, Advani R, Bondin D. Quality and Reliability of YouTube Videos as a Source of Patient
Information on Rhinoplasty. JAMA Otolaryngol Head Neck Surg 2019 Mar 01;145(3):282-283. [doi:
10.1001/jamaoto.2018.3723] [Medline: 30605207]
26. Basch CH, Hillyer GC, Garcia P, Basch CE. Content of widely viewed YouTube videos about celiac disease. Public Health
2019 Feb;167:147-151. [doi: 10.1016/j.puhe.2018.11.004] [Medline: 30682698]
27. Ferhatoglu MF, Kartal A, Ekici U, Gurkan A. Evaluation of the Reliability, Utility, and Quality of the Information in Sleeve
Gastrectomy Videos Shared on Open Access Video Sharing Platform YouTube. Obes Surg 2019 May;29(5):1477-1484.
[doi: 10.1007/s11695-019-03738-2] [Medline: 30706318]
28. Basch CH, Menafro A, Mongiovi J, Hillyer GC, Basch CE. A Content Analysis of YouTube™ Videos Related to Prostate
Cancer. Am J Mens Health 2017 Jan;11(1):154-157 [FREE Full text] [doi: 10.1177/1557988316671459] [Medline: 27694554]
29. Bernard A, Langille M, Hughes S, Rose C, Leddin D, Veldhuyzen van Zanten S. A systematic review of patient inflammatory
bowel disease information resources on the World Wide Web. Am J Gastroenterol 2007 Sep;102(9):2070-2077. [doi:
10.1111/j.1572-0241.2007.01325.x] [Medline: 17511753]
30. Singh AG, Singh S, Singh PP. YouTube for information on rheumatoid arthritis--a wakeup call? J Rheumatol 2012
May;39(5):899-903. [doi: 10.3899/jrheum.111114] [Medline: 22467934]
31. Charnock D, Shepperd S, Needham G, Gann R. DISCERN: an instrument for judging the quality of written consumer health
information on treatment choices. J Epidemiol Community Health 1999 Feb;53(2):105-111 [FREE Full text] [doi:
10.1136/jech.53.2.105] [Medline: 10396471]
32. Wong K, Doong J, Trang T, Joo S, Chien AL. YouTube Videos on Botulinum Toxin A for Wrinkles: A Useful Resource
for Patient Education. Dermatol Surg 2017 Dec;43(12):1466-1473. [doi: 10.1097/DSS.0000000000001242] [Medline:
28877151]
33. Esen E, Aslan M, Sonbahar B, Kerimoğlu RS. YouTube English videos as a source of information on breast self-examination.
Breast Cancer Res Treat 2019 Feb;173(3):629-635. [doi: 10.1007/s10549-018-5044-z] [Medline: 30443880]
34. Allam A, Schulz PJ, Krauthammer M. Toward automated assessment of health Web page quality using the DISCERN
instrument. J Am Med Inform Assoc 2017 May 01;24(3):481-487. [doi: 10.1093/jamia/ocw140] [Medline: 27707819]
J Med Internet Res 2020 | vol. 22 | iss. 4 | e15599 | p. 8https://www.jmir.org/2020/4/e15599
(page number not for citation purposes)
Mueller et alJOURNAL OF MEDICAL INTERNET RESEARCH
XSL•FO
RenderX
35. ReFaey K, Tripathi S, Yoon JW, Justice J, Kerezoudis P, Parney IF, et al. The reliability of YouTube videos in patients
education for Glioblastoma Treatment. J Clin Neurosci 2018 Sep;55:1-4. [doi: 10.1016/j.jocn.2018.07.001] [Medline:
30075980]
36. Delli K, Livas C, Vissink A, Spijkervet FK. Is YouTube useful as a source of information for Sjögren's syndrome? Oral
Dis 2016 Apr;22(3):196-201. [doi: 10.1111/odi.12404] [Medline: 26602325]
37. Reddy K, Kearns M, Alvarez-Arango S, Carrillo-Martin I, Cuervo-Pardo N, Cuervo-Pardo L, et al. YouTube and food
allergy: An appraisal of the educational quality of information. Pediatr Allergy Immunol 2018 Jun;29(4):410-416. [doi:
10.1111/pai.12885] [Medline: 29512839]
38. Wondershare. Standard YouTube License vs. Creative Commons URL: https://tinyurl.com/r692rad [accessed 2019-05-05]
39. Khanna R, Shifrin N, Nektalova T, Goldenberg G. Diet and dermatology: Google search results for acne, psoriasis, and
eczema. Cutis 2018 Jul;102(1):44;46;48. [Medline: 30138495]
40. Hay RJ, Johns NE, Williams HC, Bolliger IW, Dellavalle RP, Margolis DJ, et al. The global burden of skin disease in 2010:
an analysis of the prevalence and impact of skin conditions. J Invest Dermatol 2014 Jun;134(6):1527-1534 [FREE Full
text] [doi: 10.1038/jid.2013.446] [Medline: 24166134]
41. Lee JS, Seo HS, Hong TH. YouTube as a source of patient information on gallstone disease. World J Gastroenterol 2014
Apr 14;20(14):4066-4070 [FREE Full text] [doi: 10.3748/wjg.v20.i14.4066] [Medline: 24744597]
42. López-Jornet P, Pons-Fuster E, Ruiz-Roca JA. YOUTUBE videos on oral care of the organ or hematopoietic stem cell
transplant patients. Support Care Cancer 2017 Apr 22;25(4):1097-1101. [doi: 10.1007/s00520-016-3497-3] [Medline:
27878369]
43. Kantor R, Thyssen JP, Paller AS, Silverberg JI. Atopic dermatitis, atopic eczema, or eczema? A systematic review,
meta-analysis, and recommendation for uniform use of 'atopic dermatitis'. Allergy 2016 Oct;71(10):1480-1485 [FREE Full
text] [doi: 10.1111/all.12982] [Medline: 27392131]
44. Hanifin JM. Atopic dermatitis nomenclature variants can impede harmonization. J Invest Dermatol 2012 Feb;132(2):472-3;
author reply 473 [FREE Full text] [doi: 10.1038/jid.2011.292] [Medline: 21938010]
45. Kumar N, Pandey A, Venkatraman A, Garg N. Are video sharing web sites a useful source of information on hypertension?
J Am Soc Hypertens 2014 Jul;8(7):481-490. [doi: 10.1016/j.jash.2014.05.001] [Medline: 25064770]
46. Biggs TC, Bird JH, Harries PG, Salib RJ. YouTube as a source of information on rhinosinusitis: the good, the bad and the
ugly. J Laryngol Otol 2013 Aug;127(8):749-754. [doi: 10.1017/S0022215113001473] [Medline: 23866821]
47. Smith ML, Bergeron CD, Adler CH, Patel A, Ahn S, Towne SD, et al. Factors associated with healthcare-related frustrations
among adults with chronic conditions. Patient Educ Couns 2017 Jun;100(6):1185-1193. [doi: 10.1016/j.pec.2016.12.033]
[Medline: 28117194]
48. Gogtay NJ, Bhatt HA, Dalvi SS, Kshirsagar NA. The use and safety of non-allopathic Indian medicines. Drug Saf
2002;25(14):1005-1019. [doi: 10.2165/00002018-200225140-00003] [Medline: 12408732]
49. Schwemmer C, Ziewiecki S. Social Media Sellout: The Increasing Role of Product Promotion on YouTube. Social Media
+ Society 2018 Aug 14;4(3):205630511878672. [doi: 10.1177/2056305118786720]
50. Karimi S, Naghibi HS. Social media marketing (SMM) strategies for small to medium enterprises (SMEs). International
Journal of Information, Business and Management 2015;7(4):86.
51. Eysenbach G, Köhler C. How do consumers search for and appraise health information on the world wide web? Qualitative
study using focus groups, usability tests, and in-depth interviews. BMJ 2002 Mar 9;324(7337):573-577 [FREE Full text]
[Medline: 11884321]
52. Hansen DL, Derry HA, Resnick PJ, Richardson CR. Adolescents searching for health information on the Internet: an
observational study. J Med Internet Res 2003 Oct 17;5(4):e25 [FREE Full text] [doi: 10.2196/jmir.5.4.e25] [Medline:
14713653]
53. Carroll MW. Creative Commons and the openness of open access. N Engl J Med 2013 Feb 28;368(9):789-791. [doi:
10.1056/NEJMp1300040] [Medline: 23445090]
54. Creative Commons. URL: https://creativecommons.org/ [accessed 2019-04-30]
55. Drozd B, Couvillon E, Suarez A. Medical YouTube Videos and Methods of Evaluation: Literature Review. JMIR Med
Educ 2018 Feb 12;4(1):e3 [FREE Full text] [doi: 10.2196/mededu.8527] [Medline: 29434018]
Abbreviations
AD: atopic dermatitis
CAM: complementary and alternative medicine
GQS: Global Quality Scale
UV: ultraviolet light
J Med Internet Res 2020 | vol. 22 | iss. 4 | e15599 | p. 9https://www.jmir.org/2020/4/e15599
(page number not for citation purposes)
Mueller et alJOURNAL OF MEDICAL INTERNET RESEARCH
XSL•FO
RenderX
Edited by G Eysenbach; submitted 25.07.19; peer-reviewed by LH Lee, T Schopf; comments to author 24.09.19; revised version
received 03.10.19; accepted 17.12.19; published 24.04.20
Please cite as:
Mueller SM, Hongler VNS, Jungo P, Cajacob L, Schwegler S, Steveling EH, Manjaly Thomas ZR, Fuchs O, Navarini A, Scherer K,
Brandt O
Fiction, Falsehoods, and Few Facts: Cross-Sectional Study on the Content-Related Quality of Atopic Eczema-Related Videos on
YouTube
J Med Internet Res 2020;22(4):e15599
URL: https://www.jmir.org/2020/4/e15599
doi: 10.2196/15599
PMID:
©Simon M Mueller, Valentina N S Hongler, Pierre Jungo, Lucian Cajacob, Simon Schwegler, Esther H Steveling, Zita-Rose
Manjaly Thomas, Oliver Fuchs, Alexander Navarini, Kathrin Scherer, Oliver Brandt. Originally published in the Journal of
Medical Internet Research (http://www.jmir.org), 24.04.2020. This is an open-access article distributed under the terms of the
Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution,
and reproduction in any medium, provided the original work, first published in the Journal of Medical Internet Research, is
properly cited. The complete bibliographic information, a link to the original publication on http://www.jmir.org/, as well as this
copyright and license information must be included.
J Med Internet Res 2020 | vol. 22 | iss. 4 | e15599 | p. 10https://www.jmir.org/2020/4/e15599
(page number not for citation purposes)
Mueller et alJOURNAL OF MEDICAL INTERNET RESEARCH
XSL•FO
RenderX
